https://www.gosh.nhs.uk/news/gosh-surgeon-paolo-de-coppi-makes-first-time100-health-list/
GOSH Surgeon Paolo De Coppi makes first TIME100 Health List
2 May 2024, 2 p.m.
Professor Paolo De Coppi has been added to TIME's inaugural TIME100 Health List of the 100 most influential people in global health this year.
NIHR Professor De Coppi is a Consultant Paediatric Surgeon at Great Ormond Street Hospital (GOSH), and the Nuffield Professor in Paediatric Surgery at the UCL Institute of Child Health in London. He is also the co-lead of the NIHR GOSH Biomedical Research Centre Tissue Engineering and Regenerative Medicine Theme, with his lab team based at the Zayed Centre for Research into Rare Disease in Children.
He is the President of the European Paediatric Surgical Association (EUPSA), the largest Paediatric Surgical Association of individuals worldwide and has been an Honorary Professor at the Katholieke Universiteit Leuven, Belgium, since 2013, an Adjunct Assistant Professor at the Wake Forest Institute for Regenerative Medicine, Wake Forest University in Winston-Salem, North Carolina, since 2009 and he is an Honorary Consultant at Ospedale Pediatrico Bambino Gesù in Rome, Italy.
Professor De Coppi said: "I feel very proud to work in an environment where we can continuously go from bench to bedside and back again, to improve treatment options for patients at GOSH and around the world. I am privileged to always be surrounded by people who are better to me and this recognition is testament to the spirit of teamwork that surrounds our endeavours."
Recent research from Professor De Coppi and his collaborators has covered fields as diverse as using stem cells to follow late stage pregnancy, mapping Covid transmission in the womb, engineering intestinal grafts, he was part of the team that performed the first spina bifida surgery in the womb in the UK, and worked with pioneering multi-disciplinary teams in the separation of conjoined twins.
View the full TIME100 health list. It recognises the impact, innovation, and achievement of the world’s most influential individuals in health.
NIHR launches £13.7m investment into brain tumour research
The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
New consortium aims to help improve care for arthritis patients
A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly
Great Ormond Street Hospital joins the Circular Economy Healthcare Alliance (CEHA)
By joining CEHA, Great Ormond Street Hospital reaffirms its commitment to ‘do no harm’—not only to our patients, but to the environment and future generations.
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia
A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer